| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/04/2023 | 11.22% | Raymond James | $315 → $320 | Maintains | Outperform |
| 05/05/2023 | 0.8% | Morgan Stanley | $260 → $290 | Maintains | Equal-Weight |
| 05/05/2023 | 9.49% | Raymond James | $285 → $315 | Maintains | Outperform |
| 05/05/2023 | -4.42% | Credit Suisse | $270 → $275 | Maintains | Neutral |
| 03/16/2023 | 6.01% | JP Morgan | $300 → $305 | Upgrades | Neutral → Buy |
| 02/10/2023 | 5.31% | Barclays | $306 → $303 | Maintains | Overweight |
| 01/23/2023 | — | Edward Jones | Downgrades | Buy → Hold | |
| 01/11/2023 | -6.16% | Credit Suisse | $300 → $270 | Downgrades | Outperform → Neutral |
| 11/07/2022 | 4.27% | Credit Suisse | $301 → $300 | Maintains | Market Outperform |
| 09/14/2022 | -9.63% | Morgan Stanley | $240 → $260 | Downgrades | Overweight → Equal-Weight |
| 06/22/2022 | 2.53% | Credit Suisse | $290 → $295 | Maintains | Outperform |
| 05/23/2022 | -16.58% | Morgan Stanley | → $240 | Upgrades | Equal-Weight → Overweight |
| 05/13/2022 | -16.58% | Morgan Stanley | $250 → $240 | Maintains | Equal-Weight |
| 05/13/2022 | 0.8% | Credit Suisse | $288 → $290 | Maintains | Outperform |
| 04/26/2022 | 2.53% | Loop Capital | → $295 | Initiates Coverage On | → Buy |
| 02/10/2022 | 4.27% | Barclays | $280 → $300 | Maintains | Overweight |
| 02/10/2022 | 0.1% | Credit Suisse | $306 → $288 | Maintains | Outperform |
| 02/03/2022 | 6.36% | Credit Suisse | $303 → $306 | Maintains | Outperform |
| 01/25/2022 | -13.11% | Morgan Stanley | $265 → $250 | Maintains | Equal-Weight |
| 12/15/2021 | -7.89% | Morgan Stanley | $230 → $265 | Maintains | Equal-Weight |
| 11/11/2021 | -2.68% | Argus Research | → $280 | Upgrades | Hold → Buy |
| 11/05/2021 | -2.68% | Barclays | $267 → $280 | Maintains | Overweight |
| 11/05/2021 | -4.42% | Raymond James | $245 → $275 | Maintains | Outperform |
| 11/05/2021 | 4.97% | MKM Partners | $260 → $302 | Maintains | Buy |
| 11/05/2021 | 5.31% | Credit Suisse | $307 → $303 | Maintains | Outperform |
| 10/28/2021 | — | Northcoast Research | Downgrades | Buy → Neutral | |
| 09/28/2021 | -7.2% | Barclays | $247 → $267 | Maintains | Overweight |
| 08/09/2021 | -9.63% | Citigroup | $225 → $260 | Maintains | Buy |
| 08/06/2021 | -14.84% | Raymond James | $210 → $245 | Maintains | Outperform |
| 08/06/2021 | 6.7% | Credit Suisse | $301 → $307 | Maintains | Outperform |
| 08/06/2021 | -14.15% | Barclays | $239 → $247 | Maintains | Overweight |
| 07/15/2021 | -15.19% | Northcoast Research | $215 → $244 | Maintains | Buy |
| 07/07/2021 | -9.63% | Jefferies | $230 → $260 | Maintains | Buy |
| 07/06/2021 | -20.06% | Morgan Stanley | $210 → $230 | Maintains | Equal-Weight |
| 06/02/2021 | 4.62% | Credit Suisse | $204 → $301 | Maintains | Outperform |
| 05/11/2021 | -16.93% | Barclays | $210 → $239 | Maintains | Overweight |
| 05/07/2021 | -27.01% | Raymond James | $200 → $210 | Maintains | Outperform |
| 04/12/2021 | -27.01% | Morgan Stanley | → $210 | Initiates Coverage On | → Equal-Weight |
| 02/05/2021 | -24.92% | Cowen & Co. | $183 → $216 | Maintains | Outperform |
| 02/05/2021 | -27.01% | Citigroup | $190 → $210 | Maintains | Buy |
| 02/05/2021 | -31.18% | Credit Suisse | $202 → $198 | Maintains | Outperform |
| 02/05/2021 | -30.49% | Raymond James | $175 → $200 | Maintains | Outperform |
| 01/29/2021 | -40.57% | JP Morgan | $162 → $171 | Upgrades | Underweight → Neutral |
| 12/10/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 10/30/2020 | -37.09% | Credit Suisse | $163 → $181 | Maintains | Outperform |
| 10/23/2020 | — | MKM Partners | Upgrades | Neutral → Buy | |
| 08/11/2020 | — | Argus Research | Downgrades | Buy → Hold | |
| 06/12/2020 | -44.39% | Jefferies | $155 → $160 | Maintains | Buy |
| 06/01/2020 | -43.35% | Credit Suisse | $161 → $163 | Maintains | Outperform |
| 05/08/2020 | -47.86% | MKM Partners | $192 → $150 | Maintains | Neutral |
| 05/08/2020 | -44.04% | Credit Suisse | $196 → $161 | Maintains | Outperform |
| 05/08/2020 | -39.17% | Raymond James | $180 → $175 | Reiterates | → Outperform |
| 05/08/2020 | -44.39% | Citigroup | $175 → $160 | Maintains | Buy |
| 05/08/2020 | -54.82% | JP Morgan | $168 → $130 | Downgrades | Neutral → Underweight |
| 04/29/2020 | -41.61% | JP Morgan | $170 → $168 | Maintains | Neutral |
| 04/03/2020 | -37.44% | Raymond James | $200 → $180 | Maintains | Outperform |
| 03/03/2020 | -40.91% | JP Morgan | → $170 | Upgrades | Underweight → Neutral |
| 02/20/2020 | -27.01% | Deutsche Bank | $195 → $210 | Maintains | Buy |
| 02/12/2020 | -33.96% | CFRA | $175 → $190 | Maintains | Hold |
| 12/05/2019 | -41.96% | MKM Partners | $170 → $167 | Maintains | Neutral |
| 11/11/2019 | -38.48% | Credit Suisse | $179 → $177 | Maintains | Outperform |
| 10/22/2019 | -32.22% | Deutsche Bank | $180 → $195 | Maintains | Buy |
| 09/06/2019 | -47.52% | JP Morgan | $150 → $151 | Maintains | Underweight |
| 08/08/2019 | -32.22% | Barclays | → $195 | Initiates Coverage On | → Overweight |
| 08/02/2019 | -36.74% | Raymond James | $160 → $182 | Reiterates | → Outperform |
| 08/02/2019 | -33.96% | Citigroup | $170 → $190 | Maintains | Buy |
| 07/24/2019 | -47.86% | JP Morgan | $136 → $150 | Maintains | Underweight |
| 07/17/2019 | -33.96% | Argus Research | $165 → $190 | Maintains | Buy |
| 07/17/2019 | — | Northcoast Research | Downgrades | Buy → Neutral | |
| 04/09/2019 | -44.39% | Deutsche Bank | $150 → $160 | Maintains | Buy |
| 04/05/2019 | -40.91% | Citigroup | $145 → $170 | Maintains | Buy |
| 02/11/2019 | -48.56% | Credit Suisse | $134 → $148 | Maintains | Outperform |
| 01/08/2019 | -53.43% | Credit Suisse | $137 → $134 | Maintains | Outperform |
| 11/05/2018 | -51.34% | Deutsche Bank | $135 → $140 | Maintains | Buy |
| 11/02/2018 | -56.21% | JP Morgan | $130 → $126 | Maintains | Underweight |
| 11/02/2018 | -49.6% | Citigroup | $146 → $145 | Maintains | Buy |
| 11/02/2018 | -53.08% | BMO Capital | $134 → $135 | Maintains | Outperform |
| 09/25/2018 | -49.25% | Citigroup | $130 → $146 | Maintains | Buy |
| 08/28/2018 | -49.6% | Jefferies | $140 → $145 | Maintains | Buy |
| 08/20/2018 | -52.38% | Credit Suisse | $129 → $137 | Maintains | Outperform |
What is the target price for Motorola Solns (MSI)?
The latest price target for Motorola Solns (NYSE: MSI) was reported by Raymond James on August 4, 2023. The analyst firm set a price target for $320.00 expecting MSI to rise to within 12 months (a possible 11.22% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Motorola Solns (MSI)?
The latest analyst rating for Motorola Solns (NYSE: MSI) was provided by Raymond James, and Motorola Solns maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Motorola Solns (MSI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Motorola Solns, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Motorola Solns was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.
Is the Analyst Rating Motorola Solns (MSI) correct?
While ratings are subjective and will change, the latest Motorola Solns (MSI) rating was a maintained with a price target of $315.00 to $320.00. The current price Motorola Solns (MSI) is trading at is $287.71, which is out of the analyst's predicted range.